Serum iron concentrations following administration of two different iron preparationsDANISI, M; GUERRESI, E; LANDUCCI, G et al.Journal of international medical research. 1987, Vol 15, Num 6, pp 374-378, issn 0300-0605Article

Toxicologie et pharmacologie moléculaires: métabolisme des médicaments. Prévision d'éventuels effets secondaires toxiques = Molecular toxicology and pharmacology: drug metabolism. Prospective toxical secondary effectsMANSUY, D.1985, 21 p.Report

Pharmacocinétique chez le sujet âgé = Pharmacokinetics and elderlyBALANT, L. P; EYTAN, A; BALANT-GORGIA, A. E et al.La Lettre du pharmacologue (Boulogne). 1991, Vol 5, Num 2, pp 40-47, issn 0984-452X, 6 p.Article

Pharmacocinétique clinique des anticancéreux utilisés en hématologie = Clinical pharmacokinetics of antineoplastic drugs used in haematologyASTIER, A.Journal de pharmacie clinique (Paris). 1988, Vol 7, Num 2, pp 259-279, issn 0291-1981Article

S-adenosylhomocysteine hydrolase inhibitors as broad-spectrum antiviral agentsDE CLERCQ, E.Biochemical pharmacology. 1987, Vol 36, Num 16, pp 2567-2575, issn 0006-2952Article

Salicylate measurement: clinical usefulness and methodologyKWONG, T. C.CRC Critical reviews in clinical laboratory sciences. 1987, Vol 25, Num 2, pp 137-159, issn 0590-8191Article

Clinical pharmacokinetics of valproic acid-1988ZACCARA, G; MESSORI, A; MORONI, F et al.Clinical pharmacokinetics. 1988, Vol 15, Num 6, pp 367-389, issn 0312-5963Article

The relationship of haloperidol concentrations to therapeutic responsePERRY, P. J; PFOHL, B. M; KELLY, M. W et al.Journal of clinical psychopharmacology. 1988, Vol 8, Num 1, pp 38-43, issn 0271-0749Article

Glutathione-mediated activation of anticancer platinumIV complexesEASTMAN, A.Biochemical pharmacology. 1987, Vol 36, Num 23, pp 4177-4178, issn 0006-2952Article

Valproic acid and the liverCOTARIU, D; ZAIDMAN, J. L.Clinical chemistry (Baltimore, Md.). 1988, Vol 34, Num 5, pp 890-897, issn 0009-9147Article

Prospective comparison of traditional and pharmacokinetic aminoglycoside dosing methodsFRANSON, T. R; QUEBBEMAN, E. J; WHIPPLE, J et al.Critical care medicine. 1988, Vol 16, Num 9, pp 840-843, issn 0090-3493Article

Clinical electrophysiologic effects of a single high oral dose of amiodaroneDEHARO, J. C; DURAND, A; MACALUSO, G et al.Fundamental & clinical pharmacology. 1997, Vol 11, Num 3, pp 275-280, issn 0767-3981Article

Clinical pharmacokinetics of ticlopidineDESAGER, J.-P.Clinical pharmacokinetics. 1994, Vol 26, Num 5, pp 347-355, issn 0312-5963Article

A review of the pharmacokinetics and pharmaco-dynamics of disulfiram and its metabolitesJOHANSSON, B.Acta psychiatrica scandinavica. Supplementum. 1992, Vol 86, Num 369, pp 15-26, issn 0065-1591Conference Paper

Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. I, In vitro investigations on the kinetics of activated iosphosphamide metabolites and the determination of selective properties of DNA-interstrand and DNA-protein crosslinking mechanisms using 31P-NMR spectroscopyULMER, W.Strahlentherapie und Onkologie. 1991, Vol 167, Num 7, pp 427-433, issn 0179-7158Article

Formation of active metabolite of psychotropic drugs : an updated review of their significanceCACCIA, S; GARATTINI, S.Clinical pharmacokinetics. 1990, Vol 18, Num 6, pp 434-459, issn 0312-5963, 26 p.Article

Pharmacokinetics of 6-thiouric acid and 6-mercaptopurine in renal allograft recipients after oral administration of azathioprineCHAN, G. L. C; ERDMANN, G. R; GRUBER, S. A et al.European journal of clinical pharmacology. 1989, Vol 36, Num 3, pp 265-271, issn 0031-6970Article

In vitro kinetic studies of the reaction of hydralazine and its acetone hydrazone with pyruvic acidIWAKI, M; OGISO, T; ITO, Y et al.Journal of pharmaceutical sciences. 1988, Vol 77, Num 3, pp 280-283, issn 0022-3549Article

Iron-dependent hydroxyl radical formation and DNA damage from a novel metabolite of the clinically active antitumor drug VP-16SINHA, B. K; ELIOT, H. M; KALAYANARAMAN, B et al.FEBS letters. 1988, Vol 227, Num 2, pp 240-244, issn 0014-5793Article

On the mechanisms of association of the macrolide antibiotic erythromycin with isolated human polymorphonuclear leucocytesMAIKEL RAGHOEBAR; LINDEYER, E; VAN DEN BERG, W. B et al.Biochemical pharmacology. 1988, Vol 37, Num 17, pp 3221-3227, issn 0006-2952Article

Relation between serum digoxin concentration and the electrocardiogramSANER, H. E; LANGE, H. W; PIERACH, C. A et al.Clinical cardiology (Mahwah, NJ). 1988, Vol 11, Num 11, pp 752-756, issn 0160-9289Article

Pharmacocinétique du cefuzonam chez des volontaires sainsSAITO, A.Yakuri to chiryo. 1988, Vol 16, Num 3, pp 145-151, issn 0386-3603Article

A relationship between clomipramine brain concentration and its effect on serotonin metabolismKURATA, K; KURACHI, M; KISHITANI, K et al.Japanese journal of psychiatry and neurology. 1988, Vol 42, Num 1, pp 97-105, issn 0912-2036Article

1-(o-methoxyphenyl)piperazine is a metabolite of drugs bearing a methoxyphenylpiperazine side-chainBENFENATI, E; CACCIA, S; DELLA VEDOVA, F et al.Journal of pharmacy and pharmacology. 1987, Vol 39, Num 4, pp 312-313, issn 0022-3573Article

Chronic chlorpheniramine therapy: subsensitivity, drug metabolism, and complianceBANTZ, E. W; DOLEN, W. K; CHADWICK, E. W et al.Annals of allergy. 1987, Vol 59, Num 5, pp 341-346, issn 0003-4738Article